PTAB challenges

Proceedings overview

There are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method review) on file for US Patent 10,614,477 as of the most recent data ingest from the USPTO Open Data Portal or current web search results. This means the patent's claims have not been challenged in these specific administrative trial forums, and thus, all claims currently remain untested at the PTAB. This gives a defendant no immediate defensive leverage from PTAB invalidations.

Strategic summary

As of the current date, no claims of US Patent 10,614,477 have been canceled, sustained, or even tested through an AIA trial proceeding at the Patent Trial and Appeal Board (PTAB). This means that all claims of the patent, including the independent claims 1, 10, and 18, are currently "untested" by these specific post-grant challenges.

The absence of PTAB activity implies that the patent has not been subjected to the scrutiny of an IPR, PGR, or CBM. Therefore, there is no estoppel landscape from these proceedings to consider; a potential challenger is not barred from raising any prior-art grounds or statutory invalidity arguments (within the limits of IPR/PGR eligibility) against the patent. There are no pattern signals related to PTAB filings, such as multiple IPRs by the same petitioner or aggressive appeals by the patent owner, as no proceedings have been initiated.

Recommended next steps

• For a potential defendant facing assertion: Since no PTAB activity exists, a defendant would need to consider initiating an IPR, PGR, or CBM (if applicable) if they wish to challenge the patent's validity at the USPTO.
  • PGR Eligibility: The patent issued on April 7, 2020. The nine-month window for filing a Post-Grant Review (PGR) has long passed (it would have closed around January 7, 2021). Thus, PGR is no longer an option.
  • IPR Eligibility: Inter Partes Review (IPR) is generally available after 9 months from issuance. Since the patent issued in April 2020, an IPR could be filed. An IPR can challenge claims only on grounds of novelty (§ 102) or obviousness (§ 103) based on patents or printed publications.
  • CBM Eligibility: A Covered Business Method (CBM) review was a transitional program that ended on September 15, 2020. Even if the patent were deemed a "covered business method" (which would involve an analysis of whether it claims a method or apparatus for managing a financial product or service and is not a technological invention), the statutory deadline for filing CBM petitions has passed.
• Assessment for new PTAB challenge: Any party considering challenging US 10,614,477 at the PTAB would need to prepare an IPR petition, thoroughly analyzing prior art under §§ 102 and 103, demonstrating a reasonable likelihood of prevailing on at least one claim. The absence of prior PTAB challenges means a clean slate for the petitioner, but also that the patent owner has not had to defend these claims in this forum before.